Strategic Growth Currier has recently expanded through strategic acquisitions including Springboard Manufacturing and MOS Plastics, signaling a growth trajectory and potential cross-sell opportunities across additional healthcare device segments and post-molding services.

Board Enablement New appointments to the board of directors suggest strengthened governance and potential for expanded partnerships, joint initiatives, and access to broader networks that can facilitate large-scale deals and strategic collaborations.

Healthcare Focus With a clear emphasis on medical devices, diagnostics, drug delivery, and life sciences, Currier presents opportunities to upsell advanced cleanroom manufacturing, precision molding, sterilization management, and regulatory support to OEMs pursuing connected and patient-centric solutions.

Capacity for Scale Investments in people, processes, and ISO cleanroom capabilities (ISO 8 and ISO 7) indicate readiness to handle high-precision, regulated manufacturing for complex next‑gen therapies and biologics delivery systems, enabling scalable production for growing demand.

Executive Engagement Recent leadership changes and the company’s backing by Sheridan Capital highlight the potential for targeted outreach to senior procurement and engineering audiences, focusing on design for manufacturability, regulatory support, and end-to-end manufacturing partnerships.